Membio

About:

Membio is developing a plug-and-play platform for cell and gene therapy manufacturing.

Top Investors: IndieBio, SOSV, VU Venture Partners, Boom Capital Ventures, True Ventures

Description:

Membio's single-use 0.2-10 L benchtop bioreactor system uses a proprietary design to provide a constant environment for cells at all scales. One technique will provide the same outcomes at all scales, whether at 0.2 L, 10 L, or anywhere in between. Fully automated single-use bioreactors designed by the business to enable cost-effective and scalable manufacture.

Total Funding Amount:

$4.04M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mississauga, Ontario, Canada

Founded Date:

2018-01-01

Contact Email:

info(AT)membio.ca

Founders:

Andrew Pundsack, Ashley Keefner, Shane Kilpatrick

Number of Employees:

11-50

Last Funding Date:

2020-04-20

IPO Status:

Private

Industries: